SFNano is part of the European Nobel Project.

Nanotechnologies impact all fields of healthcare

Nanomedicine has the potential to enable early detection and prevention and to drastically improve diagnosis, treatment and follow-up of many diseases, including cancer but not only. Nanomedicine has nowadays hundreds of products under clinical trials, covering all major diseases including cardiovascular, neurodegenerative, musculoskeletal and inflammatory. Enabling technologies in all healthcare areas, nanomedicine is already accounting for more than 80 marketed products, ranging from nano-delivery and pharmaceutical to medical imaging, diagnostics and biomaterials.

Nanomedicine is nothing else than “nano in medicine”. Consequently, nanomedicine products follow the same regulations as other drugs and medical devices ensuring their safety and efficacy for the patients. For more information see the Nobel website.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *